Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Institute Of Biophysics Chinese Academy Of Sciences has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 3 actions are distributed across 3 distinct examiners and 3 distinct art units. This means that each pending application is being reviewed by a different examiner in a different art unit, resulting in a one to one ratio. MATTHEW Y LEE is the busiest examiner with 1 busiest examiner pending office action.
The lack of overlap in examiners or art units suggests that the institute's current prosecution efforts are fragmented across several specialized areas. With 3 distinct examiners for 3 pending office actions, the applicant must manage three unique examiner relationships. Furthermore, the 3 distinct art units indicate that each case is subject to different administrative standards. This decentralized environment requires a versatile strategy to address the specific requirements of each examiner within the Biotechnology & Pharmaceuticals technology area. Because the busiest examiner, MATTHEW Y LEE, only has 1 busiest examiner pending office action, there is no central point of contact for the portfolio. Practitioners must prepare for 3 independent prosecution tracks.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (67%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, MATTHEW Y | 1 | 81.5% | +18.4% |
| WANG, RUIXUE | 1 | 55.9% | +19.0% |
| BERTOGLIO, VALARIE E | 1 | 64.1% | +30.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866354 | Super-Resolution Single-Objective Light-Sheet Optical Microscopy System and Imaging System Comprising Same | LEE, MATTHEW Y | — |
| 18267379 | PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR | WANG, RUIXUE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866354 | Super-Resolution Single-Objective Light-Sheet Optical Microscopy System and Imaging System Comprising Same | LEE, MATTHEW Y | — |
| 18267379 | PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR | WANG, RUIXUE | — |
| 17746583 | Method for Inducing Pluripotent Stem Cells to Differentiate into Ventricular Cardiomyocytes In Vitro | BERTOGLIO, VALARIE E | — |
| Art Unit | Apps |
|---|---|
| 2872 | 1 |
| 1672 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18866354 | Super-Resolution Single-Objective Light-Sheet Optical Microscopy System and Imaging System Comprising Same | LEE, MATTHEW Y | 2872 | §102§103§112 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18267379 | PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR | WANG, RUIXUE | 1672 | §103§112Other | Final Rejection | — | Pending | Jan 08, 2024 |
| 17746583 | Method for Inducing Pluripotent Stem Cells to Differentiate into Ventricular Cardiomyocytes In Vitro | BERTOGLIO, VALARIE E | 1632 | Other | Non-Final OA | — | Pending | May 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitute Of Biophysics Chinese Academy Of Sciences has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Matthew Y Lee has the most, with 1 of Institute Of Biophysics Chinese Academy Of Sciences's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
